“As we prepare for the start of COMET-HF, the confirmatory Phase 3 clinical trial of omecamtiv mecarbil, we look forward to evaluating its potential to reduce the risk of adverse heart failure ...

(HealthDay News) — Elevated baseline resting heart rate (RHR) is associated with an increased risk for incident atrial fibrillation (AF) in Black adults, according to a study published online in JAMA ...